The CAR target is a neo-antigen present on the cell surface of more than 90% of ovarian cancer cells. T cells or NK cells with this CAR will seek and bind to ovarian cancer cells via the CAR and signal the immune cell to kill these dangerous cells. Cartherics is also researching how to use these CAR- cells to engage the patients own immune system to join the attack on targeted cancers.